HDAC1-IN-17

HDAC1-IN-17 is a selective HDAC1 inhibitor (IC50: HDAC1 3.7 nM; HDAC2 333.7 nM; HDAC6 33.4 nM; HDAC8 514.9 nM). HDAC1-IN-17 upregulates ACSL4 by increasing histone acetylation at the ACSL4 promoter and enhancer, induces lipid peroxidation, Ferroptosis and immunogenic cell death (accompanied by calreticulin exposure and release of damage-associated molecular patterns), and promotes systemic antitumor immunity. HDAC1-IN-17 inhibits tumor growth in esophageal squamous cell carcinoma xenograft and allograft models.

For research use only. We do not sell to patients.

  • Formula: C24H20BrN3O2
  • Molecular Weight:462.34
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00